Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NYSE:LCI

Lannett (LCI) Stock Price, News & Analysis

Lannett logo

About Lannett Stock (NYSE:LCI)

Key Stats

Today's Range
N/A
50-Day Range
$0.65
$2.51
52-Week Range
N/A
Volume
280,600 shs
Average Volume
92,067 shs
Market Capitalization
$7.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.

Receive LCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lannett and its competitors with MarketBeat's FREE daily newsletter.

LCI Stock News Headlines

Lucky Core Industries Ltd.
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar
As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.
LANNETT SHARES UPDATE
Why Lannett (LCI) Stock Is Down Today
See More Headlines

LCI Stock Analysis - Frequently Asked Questions

Lannett Company, Inc. (NYSE:LCI) posted its earnings results on Wednesday, November, 3rd. The company reported ($1.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.00) by $0.08. The business had revenue of $101.53 million for the quarter, compared to analyst estimates of $98.62 million.

Lannett's stock reverse split on the morning of Tuesday, February 7th 2023. The 1-4 reverse split was announced on Tuesday, February 7th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lannett investors own include Bristol-Myers Squibb (BMY), Akorn (AKRX), Micron Technology (MU), Skechers U.S.A. (SKX), Integrated Device Technology (IDTI), AT&T (T) and Bank of America (BAC).

Company Calendar

Last Earnings
11/03/2021
Today
11/21/2024
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
CUSIP
51601210
Employees
810
Year Founded
N/A

Profitability

Net Income
$-231,620,000.00
Pretax Margin
-62.67%

Debt

Sales & Book Value

Annual Sales
$340.58 million
Book Value
($23.34) per share

Miscellaneous

Free Float
9,354,000
Market Cap
$7.38 million
Optionable
Optionable
Beta
0.95

Social Links

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

This page (NYSE:LCI) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners